Home/Flashpoint Therapeutics/Eric Rowinsky, MD
ER

Eric Rowinsky, MD

Consulting Chief Medical Officer

Flashpoint Therapeutics

Flashpoint Therapeutics Pipeline

DrugIndicationPhase
Cancer Immunotherapy NanotherapeuticOncology (unspecified)Phase 1
Platform-derived NanotherapeuticsMultiple (Genetic, Neurological, etc.)Pre-clinical